FORBES CHRISTOPHER

CIK 00010991261 companyNEW BRUNSWICK, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001099126

Recent Transactions

50 trades

Award
Eloxx Pharmaceuticals, Inc.
Common Stock Option (right to buy)
2014-11-18+27,882→ 64,107 total
Award
Eloxx Pharmaceuticals, Inc.
Common Stock Option (right to buy)
2014-11-18$0.42/sh+3,462→ 67,569 total
Award
Eloxx Pharmaceuticals, Inc.
Common Stock Option
2013-09-13+318,000→ 2,002,193 total
Award
Eloxx Pharmaceuticals, Inc.
Common Stock Option
2013-05-17+238,372→ 1,684,193 total
Award
Eloxx Pharmaceuticals, Inc.
Common Stock Option
2013-02-19+89,016→ 1,495,821 total
Purchase
Eloxx Pharmaceuticals, Inc.
Common Stock
2012-11-26$0.16/sh+2,500→ 12,757,318 total
Award
Eloxx Pharmaceuticals, Inc.
Common Stock Options
2012-11-16+124,242→ 1,426,805 total
Award
Eloxx Pharmaceuticals, Inc.
Common Stock Options
2012-11-16+252,000→ 1,302,563 total
Conversion
Eloxx Pharmaceuticals, Inc.
Common Stock
2012-08-08$0.26/sh+4,292,583→ 12,754,818 total
Conversion
Eloxx Pharmaceuticals, Inc.
Series B Convertible Preferred Stock
2012-08-08−1,000→ 0 total
Award
Eloxx Pharmaceuticals, Inc.
Common Stock Option
2012-05-16+35,366→ 1,050,563 total
Award
Eloxx Pharmaceuticals, Inc.
Common Stock Option
2012-02-16+36,458→ 1,015,197 total
Purchase
Eloxx Pharmaceuticals, Inc.
Common Stock
2012-01-06$0.26/sh+192,308→ 8,239,021 total
Award
Eloxx Pharmaceuticals, Inc.
Common Stock Option
2011-11-16+87,500→ 1,018,739 total
Award
Eloxx Pharmaceuticals, Inc.
Common Stock Option
2011-09-30+190,000→ 931,239 total
Award
Eloxx Pharmaceuticals, Inc.
Common Stock Option
2011-05-17+37,962→ 741,239 total
Purchase
Eloxx Pharmaceuticals, Inc.
Common Stock
2011-03-22$0.28/sh+15,000→ 7,452,289 total
Award
Eloxx Pharmaceuticals, Inc.
Common Stock Option
2011-02-14+32,758→ 703,277 total
Award
Eloxx Pharmaceuticals, Inc.
Common Stock Option
2010-11-17+125,000→ 603,211 total
Award
Eloxx Pharmaceuticals, Inc.
Common Stock Option
2010-11-17+67,308→ 670,519 total
Purchase
Eloxx Pharmaceuticals, Inc.
Series B Convertible Preferred Stock
2010-06-02$1000.00/sh+1,000→ 1,000 total
Purchase
Eloxx Pharmaceuticals, Inc.
Common Stock Warrant
2010-06-02+3,125,000→ 7,091,477 total
Conversion
Eloxx Pharmaceuticals, Inc.
Common Stock
2010-05-25$0.83/sh+4,101,800→ 7,407,289 total
Award
Eloxx Pharmaceuticals, Inc.
Common Stock
2010-05-25$0.51/sh+78,469→ 3,305,489 total
Exercise/Conversion
Eloxx Pharmaceuticals, Inc.
Convertible Debenture Due 12/31/2010
2010-05-25$0.83/sh→ 0 total
Award
Eloxx Pharmaceuticals, Inc.
Common Stock
2010-05-25$0.37/sh+182,840→ 3,227,020 total
Award
Eloxx Pharmaceuticals, Inc.
Common Stock Option
2010-05-20+19,262→ 478,211 total
Purchase
Eloxx Pharmaceuticals, Inc.
Common Stock Warrant
2010-02-19+851,123→ 1,980,522 total
Purchase
Eloxx Pharmaceuticals, Inc.
Common Stock Warrant
2010-02-19+851,123→ 3,399,061 total
Purchase
Eloxx Pharmaceuticals, Inc.
Convertible Debenture Due 12/31/2010
2010-02-19→ 15,156,574 total
Purchase
Eloxx Pharmaceuticals, Inc.
Common Stock Warrant
2010-02-19+567,416→ 2,547,938 total
Purchase
Eloxx Pharmaceuticals, Inc.
Common Stock Warrant
2010-02-19+510,676→ 1,129,399 total
Purchase
Eloxx Pharmaceuticals, Inc.
Common Stock Warrant
2010-02-19+567,416→ 3,966,477 total
Award
Eloxx Pharmaceuticals, Inc.
Common Stock Option
2010-02-19+54,166→ 458,949 total
Award
Eloxx Pharmaceuticals, Inc.
Common Stock Option
2009-11-19+48,718→ 364,783 total
Award
Eloxx Pharmaceuticals, Inc.
Common Stock Option
2009-11-19+40,000→ 404,783 total
Purchase
Eloxx Pharmaceuticals, Inc.
Common Stock
2009-07-29$0.90/sh+97,778→ 2,191,799 total
Purchase
Eloxx Pharmaceuticals, Inc.
Common Stock Warrants
2009-07-29+88,000→ 529,501 total
Purchase
Eloxx Pharmaceuticals, Inc.
Common Stock Warrant
2009-07-29+89,222→ 618,723 total
Award
Eloxx Pharmaceuticals, Inc.
Common Stock Option
2009-05-06+18,077→ 316,065 total
Purchase
Eloxx Pharmaceuticals, Inc.
Common Stock
2009-03-16$0.49/sh+2,300→ 2,093,821 total
Purchase
Eloxx Pharmaceuticals, Inc.
Common Stock
2009-03-16$0.46/sh+2,300→ 2,091,521 total
Purchase
Eloxx Pharmaceuticals, Inc.
Common Stock
2009-03-16$0.51/sh+200→ 2,094,021 total
Purchase
Eloxx Pharmaceuticals, Inc.
Common Stock
2009-03-13$0.39/sh+10,200→ 2,089,221 total
Purchase
Eloxx Pharmaceuticals, Inc.
Common Stock
2009-03-12$0.36/sh+2,000→ 2,079,021 total
Purchase
Eloxx Pharmaceuticals, Inc.
Common Stock
2009-03-10$0.37/sh+2,500→ 2,077,021 total
Purchase
Eloxx Pharmaceuticals, Inc.
Common Stock
2009-03-09$0.38/sh+10,000→ 2,074,521 total
Purchase
Eloxx Pharmaceuticals, Inc.
Common Stock
2009-03-05$0.40/sh+1,000→ 2,064,521 total
Purchase
Eloxx Pharmaceuticals, Inc.
Common Stock
2009-03-04$0.38/sh+2,000→ 2,063,521 total
Purchase
Eloxx Pharmaceuticals, Inc.
Common Stock
2009-03-04$0.40/sh+5,500→ 2,061,521 total

Companies

Eloxx Pharmaceuticals, Inc.
Director, 10% Owner

Recent Filings

Address

303 GEORGE STREET SUITE 420

NEW BRUNSWICK, NJ, 08901

View on SEC.gov